Private equity firm Inflexion has invested in Lintbells, which produces nutritional supplements for pets.
Lintbells was founded in 2006 and now has two key brands, YuMOVE, a joint mobility supplement for dogs and cats, and YuMEGA, a supplement for pets’ skin and coat.
The investment will be used to support further growth of the business through the launch of new products, by enhancing Lintbells’ existing digital presence and by continuing its international expansion.
Inflexion’s investment in Lintbells follows its investment in two other businesses in the pet-care market - Medivet, the UK’s largest independent operator of veterinary practices, and Kynetec, which provides market data to companies operating in the pet care sector.
Tim Smallbone, Head of the Enterprise Fund at Inflexion, said, “We are delighted to have partnered with such a strong and motivated management team. The business is well placed to accelerate its already impressive growth in both the UK and internationally, with significant investment and R&D underpinning Lintbells’ prospects.”
John Howie, CEO and Co-founder of Lintbells, added, “We are excited to have brought on board a true partner whose international presence and sector expertise will be invaluable as we work together to drive Lintbells’ growth. We knew we had found the right partner when the Inflexion team showed the ability to quickly understand our business and what drives it. It made the process move incredibly swiftly. We look forward to working closely with them as Lintbells attracts new customers, launches new products, and enters new geographies.”